Work

Annexin A8 Drives MEK Inhibitor Resistance, Providing a Druggable Target for Pancreatic Ductal Adenocarcinoma

Year: 2026

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-25-0638

Authors: Shusaku Kurogi, Yoshiyuki Tsukamoto, Junpei Yamamura, Chisato Nakada, Tomohisa Uchida, Naganori Kamiyama, Shun Nakamura, Yuka Hirashita, Teijiro Hirashita, Takashi Kobayashi, Masafumi Inomata, Masatsugu Moriyama, Naoki Hijiya

Institutions: Oita University, Oita Prefectural Hospital

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Kurozumi Medical Foundation, Japan Society for the Promotion of Science

Awards: MAPK阻害薬耐性関連分子ANXA8を標的とした膵癌の新規治療法の開発, Elucidation of the functional role of ANXA8 in pancreatic cancer resistance to MAPK inhibitors and its therapeutic application

OpenAlex ID: W7126021058

FWCI: 2.778

Cites: 39

Cited by: 1

Related to: